Loading...

RxSight, Inc.

RXSTNASDAQ
Healthcare
Medical - Devices
$9.28
$0.55(6.30%)

RxSight, Inc. (RXST) Stock Overview

Explore RxSight, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.4/100

Key Financials

Market Cap379.7M
P/E Ratio-11.82
EPS (TTM)$-0.80
ROE-0.12%
Fundamental Analysis

AI Price Forecasts

1 Week$16.73
1 Month$12.11
3 Months$14.57
1 Year Target$28.72

RXST Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of RxSight, Inc. (RXST) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.64, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.82 and a market capitalization of 379.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;